New scan seeks to spot hidden cancer
NCT ID NCT04621435
Summary
This study is testing a new imaging agent called FAP-2286 to see if it can help doctors better find cancer that has spread (metastasized) in adults with solid tumors. Participants receive a small amount of a radioactive tracer that attaches to a protein common in many cancers, which is then seen on a PET scan. The main goals are to check the safety of the tracer and see how well it can detect tumors compared to standard imaging methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.